Baker Bros. Advisors »

Immunome shares owned by Baker Bros. Advisors

Quarter-by-quarter ownership of Immunome (IMNM) shares owned by Baker Bros. Advisors from 13F filings

Historical chart of Baker Bros. Advisors investment in Immunome

Tip: Access up to 7 years of quarterly data

All positions including Immunome held by Baker Bros. Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunome by Baker Bros. Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $1.2M 55k 21.19

More positions owned by Baker Bros. Advisors

Incyte Corporation (INCY)
BeOne Medicines Sponsored Ads (ONC)
Revolution Medicines (RVMD)
Madrigal Pharmaceuticals (MDGL)
ACADIA Pharmaceuticals (ACAD)
Kymera Therapeutics (KYMR)
Insmed Incorporated Com Par $.01 (INSM)
Celcuity (CELC)
Kodiak Sciences (KOD)
Rhythm Pharmaceuticals (RYTM)
Praxis Precision Medicines I (PRAX)
Alkermes SHS (ALKS)
Summit Therapeutics (SMMT)
Grail (GRAL)
Abcellera Biologics (ABCL)

View all positions for Baker Bros. Advisors

Top funds holding Immunome

FMR
BlackRock
State Street Corporation
Wellington Management Company
Redmile Group
PRIMECAP Management Company
Vanguard Capital Management
Driehaus Capital Management
Enavate Sciences GP
T. Rowe Price Associates
Morgan Stanley
Geode Capital Management
Silverarc Capital Management
Jpmorgan Chase & Co
Sofinnova Ventures

View all funds holding Immunome